|
⚲
|
| Qrxpharma Ltd | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001433008 |
| Sale | 2009-12-15 ($12.4 M Offered, $12.4 M Sold) |
| Fund | |
| Phone | 61294928021 |
| Address | Level 1 North Sydney Nsw, 00000 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Peter Campbell | |
| Michael Quinn | |
| Chris Campbell | |
| Warren Stern | |
| John Holaday | |
| Peter Farrell | |
| Gary Pace |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Haslam William
✚
|
0.0 | |
|
Hasley Nancy
✚
|
0.0 | |
|
Hasman Robert
✚
|
0.0 | |
|
Hassen Marissa
✚
|
0.0 | |
|
Hass John R
✚
|
0.0 | |
|
Hasson Heather L.
✚
|
0.0 | |
|
Hatch Anthony Derek
✚
|
0.0 | |
|
Hatfield Michael L
✚
|
0.0 | |
|
Hauser Private Equity Core Fund II, LLC
✚
|
0.0 | |
|
Haske Michael R
✚
|
0.0 |